Article: Barr Receives Tentative Approval for Generic Niaspan(R) 500 mg and 750 mg Extended-Release Tablets.

Barr Laboratories, Inc. today announced that it has received tentative approval from the U.S. Food & Drug Administration (FDA) for its generic version of Kos Pharmaceutical, Inc.'s (Kos) Niaspan(R) 500 mg and 750 mg Extended-Release Tablets (Niacin Extended-Release Tablet). The Company is currently challenging the validity and/or infringement of certain patents held by Kos for Niaspan 500 mg and 750 mg Extended-Release Tablets and a trial in the Federal District Court in New York is currently scheduled for December 2004.

The Company announced on May 12, 2003 that it had received tentative approval for its generic version of Kos Pharmaceutical, Inc.'s (Kos) ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!